Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results

Go back to Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
(NASDAQ: LRMR) Delayed: 3.96 +0.11 (2.86%)
Previous Close $3.85    52 Week High
Open $3.91    52 Week Low
Day High $4.07    P/E N/A 
Day Low $3.85    EPS
Volume 1,132,036